Carson Advisory’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$277K Buy
3,254
+2
+0.1% +$178 0.14% 145
2025
Q4
$257K Buy
3,252
+2
+0.1% +$157 0.13% 153
2025
Q3
$260K Buy
3,250
+2
+0.1% +$171 0.14% 144
2025
Q2
$295K Buy
3,248
+2
+0.1% +$183 0.19% 119
2025
Q1
$304K Buy
3,246
+2
+0.1% +$179 0.2% 114
2024
Q4
$295K Sell
3,244
-23
-0.7% -$2.19K 0.21% 119
2024
Q3
$339K Sell
3,267
-99
-3% -$10.1K 0.21% 119
2024
Q2
$327K Buy
3,366
+2
+0.1% +$184 0.23% 108
2024
Q1
$303K Buy
3,364
+2
+0.1% +$169 0.21% 117
2023
Q4
$268K Buy
3,362
+2
+0.1% +$150 0.21% 122
2023
Q3
$239K Sell
3,360
-131
-4% -$9.79K 0.21% 129
2023
Q2
$269K Buy
3,491
+12
+0.3% +$929 0.23% 115
2023
Q1
$261K Buy
3,479
+2
+0.1% +$149 0.23% 110
2022
Q4
$274K Buy
3,477
+52
+2% +$3.9K 0.26% 95
2022
Q3
$241K Buy
3,425
+250
+8% +$19.6K 0.27% 97
2022
Q2
$254K Sell
3,175
-41
-1% -$3.21K 0.28% 95
2022
Q1
$244K Hold
3,216
0.24% 103
2021
Q4
$274K Buy
+3,216
New +$251K 0.28% 93

Other funds holding CL

Carson Advisory's CL Position: Q1 2026 in Review

Carson Advisory increased its Colgate-Palmolive (CL) stake by 0.06% in Q1 2026, buying an estimated $178 and bringing the position to 3,254 shares worth $277K. The position accounts for 0.14% of the portfolio, ranked #145.

Carson Advisory first reported a position in CL in Q4 2021 and has held it in 18 quarters since. The position peaked at $339K in Q3 2024. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Carson Advisory held 3,254 shares of Colgate-Palmolive worth $277K as of Q1 2026.
  • Carson Advisory bought 2 Colgate-Palmolive shares in Q1 2026, an estimated $178.
  • Colgate-Palmolive made up 0.14% of Carson Advisory's portfolio in Q1 2026, its #145 holding.
  • Carson Advisory first reported a position in Colgate-Palmolive in Q4 2021 and has held it in 18 quarters since.
  • Carson Advisory's Colgate-Palmolive position peaked at $339K in Q3 2024.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Carson Advisory's 13F filing for Q1 2026, filed 7 May 2026.